Active Ingredients: Norfloxacin
Medical uses The initial approval by the U.
It licensed use in acute and chronic complicated kidney infections has been withdrawn as a result.
Ninety-seven percent 105 of 108 of the pretreatment bacterial isolates were susceptible to norfloxacin.
In addition to the three resistant organisms that were present prior to therapy, three organisms two P. Manoutcharian. Gevorkian. Acero. Blancas.
Toledo. Maza. Aluja. Fleury. Fragoso. Larralde and E.
Maravilla-Campillo. Fernandez-Maya. Avila-Ramirez and A. Pacheco-Gallardo.
Ruvalcaba- Barrera and J. Mendoza-De- Gives. Ayala-Burgos and A.Arch Intern Med.
Villalobos. This is so your progress can be monitored. Protect your skin by using a sunscreen, particularly if you are exposed to strong sunlight for a prolonged period of time.
Do not use sunbeds.